View Older Stories View More Recent Stories

Nov 5, 2019 06:00AM Pivotal Data Presented at ObesityWeek 2019 Highlight the Therapeutic Benefits of PlenityTM in Adults with Obesity and Underscore its Safety and Efficacy in Lower-BMI Overweight Adults
Oct 29, 2019 07:00AM New Plenity™ Pivotal Safety and Efficacy Data to be Presented at ObesityWeek 2019
Sep 7, 2019 06:14PM PureTech Announces Board Change
Jul 17, 2019 02:00AM PureTech Acquires New Clinical-Stage Program LYT-100 to Treat Lymphedema
Jul 9, 2019 02:00AM PureTech Announces Issuance of U.S. Patent Covering Compositions of Matter for Immuno-Oncology Program Targeting Galectin-9
Jun 20, 2019 02:00AM PureTech Establishes New Corporate Headquarters in Boston’s Seaport District to Support Expansion and Acceleration of Internal R&D Pipeline
May 30, 2019 02:05AM PureTech Health to Present at Jefferies 2019 Healthcare Conference
May 19, 2019 12:30PM Promising Clinical Data from Pilot Study of Gelesis’ Novel Hydrogel GS500 Prototype for the Potential Treatment of Chronic Constipation Presented at Digestive Disease Week by Researchers from Massac
May 14, 2019 02:00AM PureTech Health Affiliates Gelesis and Vedanta Biosciences Announce Presentations at Digestive Disease Week
Apr 25, 2019 02:00AM Gelesis Awarded $10.6 (€9.4) Million Grant to Support Commercial Manufacturing of PLENITY™
Apr 17, 2019 02:00AM PureTech Health Announces Collaboration with Boehringer Ingelheim to Advance Immuno-oncology Product Candidates using its Lymphatic Targeting Platform
Apr 14, 2019 10:15AM Gelesis Granted FDA Clearance to Market PLENITY™ — a New Prescription Aid in Weight Management
Apr 11, 2019 02:05AM Gelesis Presents Preclinical Data Showing Proprietary Hydrogel Prevents Harmful Effects of a High-Fat Diet
Apr 2, 2019 02:00AM PureTech Health Announces Presentation of Internal Immuno-Oncology Programs at American Association for Cancer Research (AACR) Annual Meeting
Mar 25, 2019 02:00PM Gelesis Presents Expanded Data Showing Impact of Gelesis100 Hydrogel on Patients with Prediabetes, Untreated Diabetes, and Elevated Insulin Resistance
Mar 25, 2019 02:00PM Gelesis Presents Preclinical Data Showing Proprietary Hydrogel Restores Gut Barrier Function
Mar 21, 2019 03:00AM Gelesis Announces Three Presentations at Annual Endocrine Society Meeting
Feb 21, 2019 02:00AM PureTech Health to Present at Two Upcoming Investor Conferences
Dec 10, 2018 02:00AM Bristol-Myers Squibb and Vedanta Biosciences Announce a New Clinical Collaboration to Evaluate OPDIVO® (nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers
Nov 13, 2018 06:05AM Pivotal Weight Loss Data for Gelesis100 Published in Obesity, Including Predictors of Response
Nov 7, 2018 02:00AM PureTech Health to Present at Jefferies 2018 London Healthcare Conference
Nov 5, 2018 02:00AM Gelesis Announces Presentations of Expanded Pivotal Data at ObesityWeek 2018
Sep 17, 2018 11:10AM PureTech Health Collaborator Publishes in Nature Neuroscience Highlighting Key Role of Brain Lymphatics in Neuroinflammatory Conditions Like Multiple Sclerosis
Jul 25, 2018 01:10PM PureTech Health Collaborator Publishes in Journal Nature Regarding New Insights into Key Role of Brain Lymphatics in Alzheimer’s and Other Neurodegenerative Diseases
Jul 20, 2018 02:00AM PureTech Health Announces Collaboration with Roche to Advance Technology for Oral Administration of Antisense Oligonucleotides
Jun 5, 2018 02:00AM Harry Leider, Former Chief Medical Officer of Walgreens, Joins Gelesis as Chief Medical Officer, and Paul Fonteyne, Chairman and Former CEO of Boehringer Ingelheim USA, Joins the Gelesis Board of Dire
May 30, 2018 02:00AM PureTech Health to Present at Jefferies 2018 Global Healthcare Conference
Apr 24, 2018 02:00AM PureTech Health Appoints Joep Muijrers as Chief Financial Officer
Mar 1, 2018 02:00AM Gelesis Raises $30 Million to Prepare for Potential Launch of Lead Product
Jan 12, 2018 10:00AM Camtek Ltd. (Nasdaq: CAMT) to Ring The Nasdaq Stock Market Closing Bell
Nov 22, 2017 02:00AM PureTech Health to Present at Piper Jaffray 2017 Healthcare Conference
Nov 9, 2017 02:00AM PureTech Health to Present at Jefferies 2017 Healthcare Conference in London
Nov 3, 2017 03:00AM Vedanta Biosciences Awarded Up To $5.4 Million from CARB-X to Accelerate Development of VE303, a Novel Human Microbiome-Derived Treatment for Serious Bacterial Infection
Sep 25, 2017 02:00AM Gelesis100 Achieves Significant Weight Loss with Excellent Safety Profile in Pivotal Study
Sep 20, 2017 02:00AM PureTech Health Notes U.S. Patent Issuance Broadly Covering Methods of Assessing Mental and Physical Condition from Human Speech
Sep 19, 2017 02:00AM PureTech Health Exclusively Licenses Novel Milk-Derived Exosome Technology for Oral Administration of Biologics, Nucleic Acids, and Complex Small Molecules
Aug 29, 2017 02:00AM PureTech Health Exclusively Licenses Glyph Technology from Monash University to Harness Lymphatic Biology
Jul 13, 2017 02:00AM PureTech Health Presents Data Supporting Treatment Approach for Interstitial Cystitis/Bladder Pain Syndrome Based on Novel Alivio Inflammation-Targeting Technology
May 25, 2017 02:00AM PureTech Health to Present at Jefferies 2017 Global Healthcare Conference
May 17, 2017 02:00AM Sync Project Announces New Investors and Accelerates Development of Personalized Music Health Platform
May 9, 2017 02:00AM PureTech Health Announces Initiation of Phase 2b mTORC1 Inhibitors Study in Elderly Patients at Increased Risk of Respiratory Tract Infections
May 5, 2017 05:13AM PureTech Health Announces Licensing Agreement between Commense and the University of British Columbia for Microbiome-Derived Therapy
Apr 13, 2017 06:00AM resTORbio Appoints Joan Mannick, M.D., as Chief Medical Officer
Apr 11, 2017 02:00AM PureTech Health Advances New Program Targeting Immunosuppressive Gamma Delta T Cells and Related Mechanisms
Apr 5, 2017 02:00PM Akili Announces Results from Pilot Study Showing Treatment with Project EVO™ Improves Cognitive Control in Children with Sensory Processing Dysfunction and Attentional Deficits
Mar 24, 2017 03:00AM PureTech Health Announces Licensing and Equity Agreement with Novartis to Advance Clinical Stage mTORC1 Programs
Mar 2, 2017 02:00AM PureTech Health Appoints Bharatt Chowrira, Ph.D., J.D., as President and Chief of Business and Strategy
Feb 24, 2017 02:00AM PureTech Health to Present at the Cowen and Company 37th Annual Health Care Conference
Feb 23, 2017 02:00AM PureTech Health Appoints Atul Pande M.D., Former SVP at GlaxoSmithKline, as Chief Medical Officer
Feb 7, 2017 02:00AM PureTech Health to Present at the Leerink Partners 6th Annual Global Healthcare Conference
View More Recent Stories View Older Stories